Impact of CYP3A5 Gene Polymorphism on Efficacy of Simvastatin

Background: One of the promises of human genetics is individualized therapy. Therefore, we evaluated the impact of CYP3A5 gene polymorphism on the effectiveness of simvastatin (a HMG-CoA reductase inhibitor). Methods: Patients (n = 191) with hypercholesterolemia were treated with simvastatin for at...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolovou, Genovefa, Ragia, Georgia, Kolovou, Vana, Mihas, Constantinos, Katsiki, Niki, Vasiliadis, Ioannis, Mavrogeni, Sophie, Vartela, Vassiliki, Tavridou, Anna, Manolopoulos, Vangelis G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959175/
https://www.ncbi.nlm.nih.gov/pubmed/24653785
http://dx.doi.org/10.2174/1874192401408010012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959175/
https://www.ncbi.nlm.nih.gov/pubmed/24653785
http://dx.doi.org/10.2174/1874192401408010012

Ejemplares similares